British babies to get vaccine against meningitis

NewsGuard 100/100 Score

Babies in the UK will soon be given a vaccination against the pneumococcal disease meningitis as part and parcel of the standard infant immunisation package.

The vaccine Prevnar will be available as early as next week and will be routinely given to babies when they are 2 months, 4 months and 13 months old.

Children under 2 who have already started their vaccinations will also be offered the jab as part of a 'catch-up' programme.

Experts believe the vaccination against pneumococcal or bacterial meningitis will save at least 50 lives a year and Health minister Caroline Flint says it will prevent hundreds of cases of such serious illnesses.

The pneumococcal bug can cause meningitis, pneumonia and blood poisoning.

Survivors are often left with permanent disabilities including brain damage, deafness and cerebral palsy, but some parents are concerned that infant immune systems will be over loaded and unable to cope with the number of vaccines now recommended.

The addition of the trio of pneumococcal jabs means children will now receive 25 vaccinations, in 10 injections, against 10 different diseases before the age of 2.

However experts say that vaccination is the only way to prevent meningitis and they welcome the move.

Prevnar is produced by the drug company Wyeth.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows potential for universal flu vaccine with broad antibody response